Paul P. Carbone's scientific contributions

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (2)


Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum
  • Article

February 1969

·

6 Reads

·

106 Citations

The American Journal of Medicine

William C. Roberts

·

Donald G. Liegler

·

Paul P. Carbone

Three patients with cardiomegaly, congestive cardiac failure and blood eosinophilia are described. Necropsy in two disclosed severe mural endocardial fibrosis with superimposed fibrin-platelet thrombi, myocardial scarring, eosinophilic hyperplasia of the bone marrow and spleen without abnormal or leukemic myeloblasts, and occasionally thrombosed small arteries in the heart, spleen, kidneys and lungs. These features are similar to those described in patients with Löffler's fibroplastic parietal endocarditis and in “eosinophilic leukemia” without abnormal myelopoiesis. It is suggested that these two conditions are the same disease. It is also suggested that the predominantly African condition, endomyocardial fibrosis without eosinophilia, may be a late or inactive stage of either Löffler's endocarditis or of “eosinophilic leukemia” without abnormal myelopoiesis.

Share

Endomyocardial disease and eosinophilia

January 1969

·

3 Reads

·

84 Citations

The American Journal of Medicine

Three patients with cardiomegaly, congestive cardiac failure and blood eosinophilia are described. Necropsy in two disclosed severe mural endocardial fibrosis with superimposed fibrin-platelet thrombi, myocardial scarring, eosinophilic hyperplasia of the bone marrow and spleen without abnormal or leukemic myeloblasts, and occasionally thrombosed small arteries in the heart, spleen, kidneys and lungs. These features are similar to those described in patients with Löffler's fibroplastic parietal endocarditis and in “eosinophilic leukemia” without abnormal myelopoiesis. It is suggested that these two conditions are the same disease. It is also suggested that the predominantly African condition, endomyocardial fibrosis without eosinophilia, may be a late or inactive stage of either Löffler's endocarditis or of “eosinophilic leukemia” without abnormal myelopoiesis.

Citations (2)


... Indeed, eosinophils have been shown to be able to cause myocardial toxicity especially due to their cationic proteins [11, 14]. According to ROBERTS et al. [15], it is likely that Lo Èffler's endocarditis, associated with other diseases, is due to the eosinophilia itself and not to an unrecognized underlying factor. In this respect Lo Èffler's endocarditis has been reported in patients with variegated eosinophilic responses, whether they were secondary to drugs or to parasitic diseases [3, 15]. ...

Reference:

Systemic lupus erythematosus, eosinophilia and Löffler's endocarditis. An unusual association
Endomyocardial disease and eosinophilia
  • Citing Article
  • January 1969

The American Journal of Medicine

... Several factors involving immune mechanisms have been suggested to play a pathogenetic role, including infections, chronic helminthic infection-related hypereosinophilia, allergy, auto-immunity, and malnutrition. One of the major pathogenetic theories states that EMF could be considered a late effect of helminthic infection-induced eosinophil degranulation in the heart,due to its similarities with the eosinophilic endocarditis (EE) of Loeffler's syndrome [2][3][4]. At the late stage of the disease, the presence of a focal perivascular chronic inflammatory infiltrate deep within the endomyocardium, predominantly composed by lymphocytes and macrophages, with very rare eosinophils is consistent with a role of persistent immunemediated inflammation [5]. ...

Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum
  • Citing Article
  • February 1969

The American Journal of Medicine